Archive

Filter

The first quarter’s economic weakness surprisingly was not attributed primarily to poor weather in the US. Instead, a sharp 7.6 percent drop in exports, partly because of economic weakness in Europe and Asia, received most of the blame. Read More

PF Growth Portfolio recommendation Allergan NYSE: AGN) is the target of an unsolicited take over offer announced late Monday, April 21. The suitor is another portfolio member, Valeant Pharmaceuticals International (NYSE: VRX), which has teamed up with activist investor William Ackman.If successful, the deal would create a global giant in… Read More